Mandatory pharmacovigilance.
Maksymowych
Walter P
WP
D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D015982:Bias; D002170:Canada; D004346:Drug Information Services / Q000592:standards*; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects; D000077339:Leflunomide; D017712:Peer Review, Research / Q000592:standards; D010506:Periodicals as Topic / Q000592:standards*; D011358:Product Surveillance, Postmarketing / Q000592:standards*; D012955:Societies, Medical
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007555:Isoxazoles; D000077339:Leflunomide